Synergistic Systems for Treating Inflammatory Bowel Disease through Peripheral Nerve Stimulation and AI-Powered Personalized Medicine

This inventive concept integrates peripheral nerve stimulation with AI, IoT, and blockchain technologies to create a personalized treatment system for inflammatory bowel disease, offering improved treatment outcomes and enhanced patient care.

The original patent disclosed a method for treating inflammatory bowel disease through peripheral nerve stimulation. However, it lacked the capability to provide personalized treatment recommendations, secure patient data management, and real-time monitoring of treatment response. The new inventive concept addresses these limitations by combining peripheral nerve stimulation with AI-powered diagnostic capabilities, IoT-enabled sensors, and blockchain-based patient data management.

The synergistic system consists of a peripheral nerve stimulation module, an AI-powered diagnostic module, and a blockchain-based patient data management system. The AI-powered diagnostic module analyzes the patient's medical history and provides personalized treatment recommendations. The peripheral nerve stimulation module delivers targeted electrical stimulation to the patient's peripheral nerves based on the AI-recommended treatment plan. The blockchain-based patient data management system securely stores and updates the patient's treatment records, ensuring data integrity and confidentiality. The system also incorporates IoT-enabled sensors to monitor the patient's vital signs and treatment response, transmitting the data to a cloud-based server for analysis and feedback.

The new inventive concept is novel and non-obvious in its combination of peripheral nerve stimulation with AI-powered diagnostics, IoT-enabled sensors, and blockchain-based patient data management. The integration of these distinct technologies enables personalized treatment recommendations, real-time monitoring, and secure data management, which are not possible with the original patent's method.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT sensor configurations, or alternative blockchain-based data management systems. Additionally, the system could be adapted for treating other inflammatory diseases or expanded to include additional diagnostic modalities.

The synergistic system has significant commercial potential in the healthcare industry, particularly in the treatment of inflammatory bowel disease. The system's ability to provide personalized treatment recommendations, real-time monitoring, and secure data management addresses a significant unmet need in the market. The target industries include pharmaceutical companies, medical device manufacturers, and healthcare providers.